LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
MDA-MB-231 Sorafenib
0.37
uM
LJP6
1
B10
72
hr
1235 4389 4513 0.9724 0.9620
MDA-MB-231 Torin1
0.37
uM
LJP6
1
O16
72
hr
1235 1506 4513 0.3337 0.0824
MDA-MB-231 Withaferin A
0.37
uM
LJP6
2
G16
72
hr
1235 2415 4513 0.5350 0.3597
MCF 10A GW843682X
0.12
uM
LJP6
3
B17
72
hr
962 6931 10605 0.6536 0.6190
MDA-MB-231 Withaferin A
0.37
uM
LJP6
1
G16
72
hr
1235 2304 4513 0.5105 0.3259
MDA-MB-231 SNS-032
1.11
uM
LJP6
3
H15
72
hr
1235 525 4513 0.1163 -0.2169
MDA-MB-231 AT-7519
1.11
uM
LJP6
2
K03
72
hr
1235 195 4513 0.0432 -0.3176
MDA-MB-231 Y39983
0.37
uM
LJP6
2
P04
72
hr
1235 2995 4513 0.6635 0.5367
MDA-MB-231 WYE-125132
0.37
uM
LJP6
2
L10
72
hr
1235 1564 4513 0.3465 0.1001
MDA-MB-231 Y39983
0.37
uM
LJP6
1
P04
72
hr
1235 3162 4513 0.7005 0.5876
MDA-MB-231 AT-7519
1.11
uM
LJP6
1
K03
72
hr
1235 301 4513 0.0667 -0.2853
MDA-MB-231 Afatinib
1.11
uM
LJP6
2
G21
72
hr
1235 2709 4513 0.6002 0.4494
MDA-MB-231 Alvocidib
1.11
uM
LJP6
3
A15
72
hr
1235 491 4513 0.1088 -0.2273
MDA-MB-231 SNS-032
1.11
uM
LJP6
2
H15
72
hr
1235 470 4513 0.1041 -0.2337
MDA-MB-231 AZD7762
1.11
uM
LJP6
1
L03
72
hr
1235 718 4513 0.1591 -0.1580
MDA-MB-231 AZD 5438
1.11
uM
LJP6
1
J03
72
hr
1235 913 4513 0.2023 -0.0985
MDA-MB-231 AZD 5438
1.11
uM
LJP6
3
J03
72
hr
1235 935 4513 0.2072 -0.0918
MDA-MB-231 SNS-032
1.11
uM
LJP6
1
H15
72
hr
1235 582 4513 0.1289 -0.1995
MDA-MB-231 AZD8055
1.11
uM
LJP6
2
A09
72
hr
1235 1908 4513 0.4227 0.2050
MDA-MB-231 BMS345541
1.11
uM
LJP6
3
D03
72
hr
1235 3147 4513 0.6972 0.5831